These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A clinical evaluation of miltown (2 methyl-2-N-propyl-1, 3 propanediol dicarbamate). WEINSTEIN GJ N Y State J Med; 1957 Jun; 57(12):2060. PubMed ID: 13441048 [No Abstract] [Full Text] [Related]
4. [Clinical use of a new drug with sedative action: 2-methyl-2-n-propyl-1, 3-propanediol dicarbamate]. RIGOTTI S Minerva Med; 1956 Dec; 47(102):2178-81. PubMed ID: 13399941 [No Abstract] [Full Text] [Related]
5. [Effects of administration of 2-methyl-2-n-propyl-1, 3-propanediol dicarbamate (meprobamate) in mental disorders]. IMBERCIADORI S; MANGANARO D Minerva Med; 1956 Dec; 47(102):2181-4. PubMed ID: 13399942 [No Abstract] [Full Text] [Related]
6. [Effect of 2-methyl-2-N-propyl-1,3-propanediol dicarbamate (meprobamate) on the spinal electric potential in frogs]. RAPUZZI G; DOZIO G Arch Ital Sci Farmacol; 1958 Jan; 8(1):74-84. PubMed ID: 13522415 [No Abstract] [Full Text] [Related]
7. Psychiatric use of a new tranquilizer: 2-methyl-2-N-propyl-1,3-propanediol dicarbamate (meprobamate). MACCAGNANI G Rass Neuropsichiatr; 1957; 11(3-4):145-71. PubMed ID: 13506106 [No Abstract] [Full Text] [Related]
8. Preliminary institutional evaluation of a new drug in cerebral palsy: N-isopropyl-2-methyl-2-propyl-1,3-propanediol dicarbamate (soma). PHELPS WM Arch Pediatr (N Y); 1959 Jun; 76(6):243-50. PubMed ID: 13662106 [No Abstract] [Full Text] [Related]
11. [Action of 2-methyl-2-propyl-1,3-propanediol dicarbamate in rabbits; bioelectric & symptomatological aspects]. MONTANINI R; TERRANOVA R G Psichiatr Neuropatol; 1957; 85(2):401-11. PubMed ID: 13462246 [No Abstract] [Full Text] [Related]
12. [Pharmacological action of 2-methyl-2-propyl-1,3-propanediol dicarbamate. II. Antagonism with morphine]. SCARINCI V Boll Soc Ital Biol Sper; 1957 Jul; 33(7):1165-7. PubMed ID: 13510472 [No Abstract] [Full Text] [Related]
13. [Effects of 2 methyl-2- (1 methyl propyl) 1-3 propanediol dicarbamate and (alpha bromo-alpha-ethyl butyryl) urea on glycemia of rabbits]. Sassine A; Rechencq E; Bourgeois JM J Physiol (Paris); 1969; 61 Suppl 2():400. PubMed ID: 4393692 [No Abstract] [Full Text] [Related]
14. Preliminary trial of a new muscle relaxant; nisopropyl-2-methyl-2-propyl-1,3 propanediol dicarbamate (soma) in outpatient children with cerebral palsy. SPEARS CE; PHELPS WM Arch Pediatr (N Y); 1959 Jul; 76(7):287-92. PubMed ID: 13662111 [No Abstract] [Full Text] [Related]
15. [Use of 2-methyl-2-N-propyl-1, 3-propanediol dicarbamate in psychiatry]. FLORIS V; RAMBELLI L Minerva Med; 1956 Nov; 47(88):1455-7. PubMed ID: 13387286 [No Abstract] [Full Text] [Related]
16. Toxic reaction to 2-methyl-2-n-propyl-1, 3, propanediol dicarbamate (miltown and equanil). HOLOUBEK JE; THOMAS OC; SEGURA J Ann Intern Med; 1957 May; 46(5):1002-4. PubMed ID: 13411911 [No Abstract] [Full Text] [Related]
17. Gas chromatographic determination of meprobamate, 2-methyl-2-propyl-1,3-propanediol dicarbamate, in plasma and urine. Douglas JF; Kelley TF; Smith NB; Stockage JA Anal Chem; 1967 Jul; 39(8):956-8. PubMed ID: 6042638 [No Abstract] [Full Text] [Related]
18. [Pharmacological actions of 2-methyl-2-n-propyl-1, 3-propandiol dicarbamate. I. Actions on experimental epilepsy]. SCARINCI V Arch Ital Sci Farmacol; 1957 Apr; 7(2):113-8. PubMed ID: 13459617 [No Abstract] [Full Text] [Related]
19. [2-Methyl-2-n-propyl-1, 3-propandiol-dicarbamate (meprobamate); experimental results, clinical experiences and own studies on the determination of excretion products]. RIEBELING C Arzneimittelforschung; 1957 Mar; 7(3):181-5. PubMed ID: 13425940 [No Abstract] [Full Text] [Related]
20. [A new therapeutic agent against anxiety states; meprobamate (2-methyl-2-N-propyl-1, 3-propandiol dicarbamate)]. SPOTA BB Sem Med; 1957 Feb; 110(7):237-8. PubMed ID: 13454968 [No Abstract] [Full Text] [Related] [Next] [New Search]